Dr. Eric K. Singhi

There is a particular kind of fear that settles in after a lung cancer diagnosis — not just fear of the disease, but fear of the waiting.

Understand the difference between targeted therapy, chemotherapy, and immunotherapy in lung cancer — and why starting the wrong treatment first can be harmful for patients with targetable mutations.

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and oncologists about the life-changing importance of knowing your mutation first.

Dr. Eric Singhi sat down with CURE to break down the findings from the phase 3 FLAURA2 study, presented at the 2025 IASLC World Conference on Lung Cancer.

Expert oncologists Dr. Joshua K. Sabari and Dr. Eric K. Singhi break down key updates and takeaways in lung cancer treatment following ASCO 2025.

Two colleagues of Amy Wallace, an oncology nurse, nominated her for the Extraordinary Healer Award based on her care of patients with lung cancer.